Metastatic bone disease
Characteristic of risk factor of thyroid cancer related metastatic bone disease at Sanglah General Hospital Denpasar between January 2013 to March 2019
... Background: Metastatic bone disease (MBD) causes a massive morbidity, pain, and disability for the ...experience bone metastasis. An urgency to further analyze the risk factors of bone ...
5
Metastatic Bone Disease - A Review of Literature
... with metastatic bone disease (MBD) as bad, the literature showed good quality life span to these group of ...exclusive bone secondaries has been ...in metastatic bone ...
12
Metabolic effects of pamidronate in patients with metastatic bone disease
... Summary We have evaluated the value of specific bone resorption markers in monitoring metastatic bone disease to define the duration of action of a single high-dose pamidronate infusion.[r] ...
7
A scoping review on the surgical management of metastatic bone disease of the extremities
... with metastatic bone disease of the extrem- ities (MBD-E), breast cancer, lung cancer, renal cell can- cer, prostate cancer and multiple myeloma contributed to 78% of tumours in the Scandinavian ...
10
Zoledronic acid in the management of metastatic bone disease
... decreased bone strength due to metastatic foci, underlying osteoporosis and/or cancer treatment induced bone ...of metastatic disease involving the skeleton are ...of metastatic ...
8
Bone resorption predicts for skeletal complications in metastatic bone disease
... in bone and its breakdown products are being increasingly investigated as markers of bone ...in metastatic bone disease (Lipton et al, ...between bone resorption markers, ...
7
Estimated number of prevalent cases of metastatic bone disease in the US adult population
... of metastatic bone disease to supplement the diagno- sis code should help improve sensitivity, but this also presents ...of metastatic bone disease remains unknown until a ...
7
A short account of metastatic bone disease
... osteolytic metastatic bone disease ...with metastatic cells also starts with a phase of abnormal bone resorption, and only later in the course of the metastatic bone ...
6
Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management.
... Several clinical trials demonstrated that, among N-BPs, zoledronate was the most effective for SRE prevention in both MM and solid tumors, while a significant improvement of survival outcomes was reached only Fig. 4. ...
13
Compartmental Model for 223Ra-Dichloride in Patients With Metastatic Bone Disease From Castration-Resistant Prostate Cancer.
... two treatments is a factor that must be taken into account and further studies with a larger patient cohort are necessary to improve the population model. Nevertheless, similar pharmacokinetic profiles have been observed ...
34
Survival Rates Following Skeletal Metastases—A Twenty Year Analysis
... Skeletal metastases most commonly originate from primary tumours of the lung, prostate, breast and kidney [4] [10] [11]. A study identified the survival period following the diagnosis of skeletal metastases originating ...
9
The Role of Physical Activity for Patients with Advanced Cancer
... with bone metastases secondary to advanced ...all bone metastases are likely to cause fracture, and little is known about the actual association between physical activity levels and fracture rates (Chapter ...
323
Opposite prognostic roles of HIF1 aand HIF2a expressions in bone metastatic clear cell renal cell cancer
... The simplistic VHL-HIF pathway driven angiogenic phenotype of ccRCC underwent a considerable redefinition recently. It was discovered by deep sequencing analysis that ccRCC can be further subclassified on the basis of ...
13
Clinical Characteristics and efficacy of chemotherapy in sclerosing epithelioid fibrosarcoma.
... These findings suggest that SEF has a chemo-sensitivity in keeping with a large proportion of other STS subtypes, where occasional tumour sensitivity is demonstrated in the context of likely limited benefit delivered to ...
7
PROGRESSION OF BREAST CANCER METASTATIC DISEASE AND SUBSEQUENT OSTEOLYTIC BONE DEGRADATION MEDIATED BY ONCOSTATIN M
... During the progression of malignant disease, morbidity and mortality do not occur due to the primary tumor in the majority of the cases. Metastasis of the primary tumor cells to secondary vital organs leads to ...
212
Management and Outcomes in Primary Tumors of the Appendix
... Upon further review of the pathologic subsets as shown in Table 3, of the 19 patients who presented with either adenocarcinoma or mixed adenocarcinoma and goblet cell carcinoid, 10 were suspected peroperatively, either ...
7
Metastatic Disease: Interactions Between Tumor Cells and Host Environment During Cancer Cell Spread
... of metastatic disease, treatment of one facet of patient health can have an impact on overall patient outcome, potentially beyond the expected mechanism of the ...
160
Parameningeal Rhabdomyosarcoma: Single Institution Retrospective Study
... Results: The median age of presentation was 4 years. Majority of patients presented with proptosis and stage III/IV disease. Positive cytology in CSF was the commonest site of metastasis. Embryonal histology was ...
5
Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells
... It has been proposed that cancer cells invading the brain often die at the brain site. In order to survive in the “hostile” brain microenvironment, cancer cells must overcome apoptotic signals and coopt other surviving ...
13
Brain metastases in newly diagnosed colorectal cancer: a population-based study
... Results: We identified 170,793 adult patients diagnosed with CRC between 2010 and 2013. From these patients, we identified 401 patients with BM at the time of CRC diagnosis, which represents 0.23% of the entire patient ...
10